JOSEPH FRANCIS MURPHY, PH. D.

attorney directory

alternative dispute resolution team

anda litigation team

biotechnology patent team

chemistry & chemical engineering patent team

electronics & it patent team

litigation team

mechanical engineering patent team

medical instruments/devices patent team

pharmaceuticals patent team

trademark team

transactional matters team

other professionals

JOSEPH FRANCIS MURPHY, PH. D.

ASSOCIATE

TELEPHONE: 215-567-2010.
EXTENSION
FAX: 215-751-1142

jmurphy@crbcp.com

Dr. Murphy's practice includes the drafting and prosecution of patents in the biotechnological, chemical, and pharmaceutical arts. He prepares Paragraph IV Certifications for submission to the FDA with ANDA filings, and also Paragraph IV Certification Notice Letters. Dr. Murphy also counsels clients with regard to the scope of the coverage of their intellectual property, and their freedom to operate. Dr. Murphy has been involved in the prosecution of Inter Partes Reexaminations, and prosecution before the Board of Patent Appeals and Interferences. Prior to joining the firm, Dr. Murphy worked for 6 years in the United States Patent and Trademark Office as a Biotechnology Patent Examiner with Full Signatory Authority and was a Master's Level Examiner for patents in the biotechnological arts. Dr. Murphy received his Ph.D. in Physiology from the University of Virginia in 1997. He did his post-doctoral fellowship at the A.I. DuPont Institute in the Epithelial Cell Biology Laboratory. From 1997 to 1999, he served as a Post Doctoral Scientist for Message Pharmaceuticals, Inc. developing assays for secondary screening of compounds that target RNA.

Teva Pharmaceutical Industries, Ltd. v. Hetero Drugs, Ltd. (D. Md. 2007), represented generic manufacturer in litigation involving anti-depressant Zoloft® (sertaline hydrochloride)

Teva Pharmaceutical Industries, Ltd. v. Apotex, Inc. (D. N.J. 2007) represented ANDA applicant in litigation involving anti-depressant Zoloft® (sertaline hydrochloride)

Teva Pharmaceutical Industries, Ltd. v. Apotex, Inc. (D. Md. 2007) represented ANDA applicant in litigation involving anti-depressant Zoloft® (sertaline hydrochloride)